RonacMamtaniMDMSCE

Oncology • Philadelphia, PA

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Mamtani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mamtani's full profile

Already have an account?

Office
3400 Civic Center Blvd
2 West
Philadelphia, PA 19104
Phone+1 215-615-5858

Fax+1 212-746-6692

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2009 - 2012
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2006 - 2009
Stony Brook University Health Sciences Center School of MedicineClass of 2006

Certifications & Licensure

PA State Medical License 2009 - 2024
NY State Medical License 2008 - 2010
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer.
Jacob B Reibel, Lova L Sun, Ravi B Parikh, Nadim Mahmud, Lainie P Martin
Journal of the National Cancer Institute. 2024-12-03
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.
Aude Fléchon, Rafael Morales-Barrera, Thomas Powles, Ajjai Alva, Mustafa Özgüroğlu
Clinical Cancer Research. 2024-12-02
1 citations
Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer.
Ronac Mamtani, Ernesto Ulloa-Pérez, Ravi B Parikh, Khilna Patel, Blanca Homet Moreno
European Urology. 2024-11-01

Journal Articles

Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs Data
Ravi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer

Authored Content

A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018

Press Mentions

Platinum Chemotherapy Drugs' Shortages and Cancer MortalityDecember 14th, 2024
Shortages of Generic Platinum Chemotherapy Did Not Result in an Increase in DeathsDecember 14th, 2024
Generic Platinum Chemotherapy Shortages Did Not Increase DeathsDecember 13th, 2024
Join now to see all

Other Languages

Hindi